China's Emergence in Global Biopharma Manufacturing: Trends in the Chinese Biopharma Industry

This four-part educational series, sponsored by BioProcess International and BioPlan Associates, Inc., highlights key trends emerging in China biopharmaceuticals, using select content BioPlan Associates’ 2018 2nd edition report, Advances in Biopharmaceutical Technology in China, 2nd Ed.

The quarterly series, each consisting of articles, an e-book, 40-min webcast, and live presentation at select BPI Events cover China’s Emergence in Global Biopharma Manufacturing: Trends in Chinese Biopharma Industry. The projects include an Overview, Developments in Biologics, Biosimilars, and Global Expansion. The series will cover key content from the 2nd Ed Advances in Biopharmaceutical Technology in China, a unique, peer-reviewed study that incorporates the research and work from over 100 global industry expert authors, many based in China. The market for biopharmaceuticals, supplies, services, and materials in China have expanded rapidly, as the government, investors, and companies, both domestic and international, have focused attention on the growing healthcare markets, and opportunities in China. The need for peer-reviewed insights into the current and future potential in China is required for the global industry to meet the needs of this rapidly expanding market.